Australasian Gastro-Intestinal Trials Group

Quick facts

Phase 3 pipeline

• Pegylated G-CSF · Oncology
  Pegylated G-CSF stimulates the production of white blood cells, specifically neutrophils, to help the body fight infection.
• Trifluridine/Tipracil · Oncology
  Trifluridine/Tipracil is an antiviral drug that works by inhibiting thymidylate synthase and dihydrofolate reductase.

Phase 2 pipeline

• BNC 105
• Cessation of somatostatin analogues
• Continuation of somatostatin analogues
• LSTA1
• Mitomycin C; Capecitabine; Bevacizumab
• octreotate · Other

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Australasian Gastro-Intestinal Trials Group portfolio CI brief
• Australasian Gastro-Intestinal Trials Group pipeline updates RSS